By Fineline Cube 
BeiGene, Ltd. (NASDAQ: ONC, HKG: 6160, SHA: 688235), the China-based oncology company that has proposed changing its name to BeOne Medicines Ltd., has announced plans to relocate its registered address from the Cayman Islands to Switzerland. This strategic move follows the establishment of its European headquarters in Switzerland in 2022.
Relocation and Re-registration Details
The company will re-register as a Swiss joint-stock company while initiating deregistration proceedings in the Cayman Islands. This transition underscores BeiGene’s commitment to strengthening its global presence and operational efficiency.
Share Issuance to Cayman Islands Subsidiary
In a related move, BeiGene will issue newly created shares totaling 133 million to its Cayman Islands subsidiary, BGNC 2, Ltd. These shares will maintain their existing overseas listings exclusively on the NASDAQ and Hong Kong Stock Exchange.-Fineline Info & Tech